![Bertil Lindkvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bertil Lindkvist
No open positions remaining
Net worth: 944 463 $ as of 30/09/2026
Finance
Profile
Bertil Lindkvist worked as a Director at Mertiva AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes 6.04% | 31/03/2026 | 9,150,000 ( 6.04% ) | 944 463 $ | 30/09/2026 |
Former positions of Bertil Lindkvist
| Companies | Position | End |
|---|---|---|
| MERTIVA AB | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Mertiva AB
 Mertiva AB Financial ConglomeratesFinance Operates as an investment company | Finance |
- Stock Market
- Insiders
- Bertil Lindkvist
